SC 13G/A

AMENDMENT NO. 5 TO THE SCHEDULE 13G

Company: Eledon Pharmaceuticals, Inc.
Filed: January 11, 2022
Accession Number: 0000921895-22-000116

View Document ↗ View on SEC.gov ↗